Insider Transactions in Q4 2023 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2023
|
William Meury President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,694
-22.84%
|
$2,747,304
$316.3 P/Share
|
|
Dec 28
2023
|
William P Kane Jr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,828
-21.68%
|
$1,209,648
$316.3 P/Share
|
|
Dec 08
2023
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.72%
|
$2,020,000
$202.51 P/Share
|
|
Dec 08
2023
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+12.14%
|
$850,000
$68.55 P/Share
|
|
Nov 08
2023
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.71%
|
$885,000
$177.18 P/Share
|
|
Nov 08
2023
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.19%
|
$510,000
$68.55 P/Share
|
|
Oct 09
2023
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.15%
|
$865,000
$173.37 P/Share
|
|
Oct 09
2023
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.79%
|
$510,000
$68.55 P/Share
|